Encompass Health Corp
(NYSE:EHC)
$
102.94
0.1 (0.1%)
Market Cap: 10.37 Bil
Enterprise Value: 13.01 Bil
PE Ratio: 24.86
PB Ratio: 5.30
GF Score: 82/100 Encompass Health Corp at UBS Global Healthcare Conference Transcript
May 24, 2022 / 01:15PM GMT
Release Date Price:
$50.57
(-0.72%)
Andrew Mok
UBS Investment Bank, Research Division - Analyst
Hi. Good morning, and welcome back to the UBS Healthcare Conference. My name is Andrew Mok. I'm the U.S. health care providers analyst at UBS. And I'm pleased to be joined on stage with Encompass CEO, Mark Tarr; and Encompass CFO, Doug Coltharp. Welcome.
Mark J. Tarr
Encompass Health Corporation - CEO, President & Director
It's great to be here.
Questions & Answers
Andrew Mok
UBS Investment Bank, Research Division - Analyst
To start, Mark, IRF volumes have been very strong in recent quarters, including 8% discharge growth in the first quarter of this year. How should we think about the sustainability of that volume growth?
Mark J. Tarr
Encompass Health Corporation - CEO, President & Director
Yes. So we do think it's sustainable. If you look at the underlying factors, by the way, first quarter was a very challenging quarter. So we were very proud of the volume that we had in both the IRF and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot